Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism
Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. W G Ding , E Renström , P Rorsman , K Buschard and J Gromada Department of Islet Cell Physiology, Kommunehospitalet, Copenhagen, Denm...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 46; no. 5; pp. 792 - 800 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
American Diabetes Association
01.05.1997
|
Online Access | Get full text |
Cover
Loading…
Summary: | Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells
by a protein kinase A-mediated mechanism.
W G Ding ,
E Renström ,
P Rorsman ,
K Buschard and
J Gromada
Department of Islet Cell Physiology, Kommunehospitalet, Copenhagen, Denmark.
Abstract
High-resolution capacitance measurements were used to explore the effects of the gut hormones GLP-I(7-36) amide [glucagon-like
peptide I(7-36) amide] and GIP (glucose-dependent insulinotropic polypeptide) on Ca2+-dependent exocytosis in glucagon-secreting
rat pancreatic alpha-cells. Both peptides produced a greater than threefold potentiation of secretion evoked by voltage-clamp
depolarizations, an effect that was associated with an approximately 35% increase of the Ca2+ current. The stimulatory actions
of GLP-I(7-36) amide and GIP were mimicked by forskolin and antagonized by the protein kinase A (PKA)-inhibitor Rp-8-Br-cAMPS.
The islet hormone somatostatin inhibited the stimulatory action of GLP-I(7-36) amide and GIP via a cyclic AMP-independent
mechanism, whereas insulin had no effect on exocytosis. These data suggest that the alpha-cells are equipped with receptors
for GLP-I and GIP and that these peptides, in addition to their well-established insulinotropic capacity, also stimulate glucagon
secretion. We propose that the reported inhibitory action of GLP-I on glucagon secretion is accounted for by a paracrine mechanism
(e.g., mediated by stimulated release of somatostatin that in turn suppresses exocytosis in the alpha-cell). |
---|---|
ISSN: | 0012-1797 1939-327X 0012-1797 |
DOI: | 10.2337/diabetes.46.5.792 |